{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Quinazolinone", "apoptosis", "benzenesulfonamide", "caspase", "cytotoxicity"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34894963", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "23"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "23"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1080/14756366.2021.1983807"], "Journal": {"ISSN": "1475-6374", "JournalIssue": {"Volume": "37", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Dec"}}, "Title": "Journal of enzyme inhibition and medicinal chemistry", "ISOAbbreviation": "J Enzyme Inhib Med Chem"}, "ArticleTitle": "Novel sulphonamide-bearing methoxyquinazolinone derivatives as anticancer and apoptosis inducers: synthesis, biological evaluation and <i>in silico</i> studies.", "Pagination": {"StartPage": "86", "EndPage": "99", "MedlinePgn": "86-99"}, "Abstract": {"AbstractText": ["We synthesised a new series of sulphonamide-bearing quinazolinone derivatives <b>5-18</b> and evaluated their <i>in\u00a0vitro</i> cytotoxicity in various cancer cell lines (A549, HepG-2, LoVo and MCF-7) and in normal human cells (HUVEC). Compounds <b>6</b> and <b>10</b> exhibited the higher activity against all the cancer cell lines compared with 5-flourourcil as positive control. The ability of the most promising compounds <b>6</b> and <b>10</b> to induce cell cycle arrest and apoptosis in breast cancer (MCF-7) cells was evaluated by flow cytometry. Reverse transcriptase-polymerase chain reaction and western blotting were used to evaluate the expression of apoptosis-related markers. We found that the 2-tolylthioacetamide derivative <b>6</b> and the 3-ethyl phenyl thioacetamide derivative <b>10</b> exhibited cytotoxic activity comparable to that of 5-fluorouracil as reference drug in MCF-7 and LoVo colon cancer cells. Cell cycle analysis showed a concentration-dependent accumulation of cells in the sub-G1 phase upon treatment with both compounds. The Annexin V-fluorescein isothiocyanate/propidium iodide assay showed that the compounds <b>6</b> and <b>10</b> increased the early and late apoptosis cell death modes in a dose-dependent manner. These compounds downregulated the expression of B-cell lymphoma-2 (Bcl-2), while increasing that of p53, Bcl-2-like protein 4, and caspase-7, at the mRNA and protein levels. Molecular docking of compounds <b>6</b> and <b>10</b> with Bcl-2 predicted them to show moderate\u2009-\u2009high binding affinity (<b>6</b>: -7.5\u2009kcal/mol, <b>10</b>: -7.9\u2009kcal/mol) and interactions with key central substrate cavity residues. Overall, compounds <b>6</b> and <b>10</b> were found to be promising anticancer and apoptosis-inducing agents."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Medicinal, Aromatic and Poisonous Plants Research Center, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}], "LastName": "Alqahtani", "ForeName": "Ali S", "Initials": "AS"}, {"Identifier": ["0000-0003-4250-0452"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt."}], "LastName": "Ghorab", "ForeName": "Mostafa M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal, Aromatic and Poisonous Plants Research Center, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}], "LastName": "Nasr", "ForeName": "Fahd A", "Initials": "FA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Medicinal, Aromatic and Poisonous Plants Research Center, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}], "LastName": "Ahmed", "ForeName": "Mohammad Z", "Initials": "MZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal, Aromatic and Poisonous Plants Research Center, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}], "LastName": "Al-Mishari", "ForeName": "Abdullah A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}], "LastName": "Attia", "ForeName": "Sabry M", "Initials": "SM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Enzyme Inhib Med Chem", "NlmUniqueID": "101150203", "ISSNLinking": "1475-6366"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinazolinones"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfonamides"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Quinazolinones"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Sulfonamides"}], "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Clark W. Tumour progression and the nature of cancer. Br J Cancer 1991;64:631\u201344.", "ArticleIdList": ["PMC1977704", "1911211"]}, {"Citation": "DeVita VT, Chu E.. A history of cancer chemotherapy. Cancer Res 2008;68:8643\u201353.", "ArticleIdList": ["18974103"]}, {"Citation": "Arruebo M, Vilaboa N, S\u00e1ez-Gutierrez B, et al. . Assessment of the evolution of cancer treatment therapies. Cancers (Basel ) 2011;3:3279\u2013330.", "ArticleIdList": ["PMC3759197", "24212956"]}, {"Citation": "Schirrmacher V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review). Int J Oncol 2019;54:407\u201319.", "ArticleIdList": ["PMC6317661", "30570109"]}, {"Citation": "Peitzsch C, Perrin R, Hill RP, et al. . Hypoxia as a biomarker for radioresistant cancer stem cells. Int J Radiat Biol 2014;90:636\u201352.", "ArticleIdList": ["24844374"]}, {"Citation": "Sugrue T, Lowndes NF, Ceredig R.. Hypoxia enhances the radioresistance of mouse mesenchymal stromal cells. Stem Cells 2014;32:2188\u2013200.", "ArticleIdList": ["24578291"]}, {"Citation": "Daniel KG, Gupta P, Harbach RH, et al. . Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells. Biochem Pharmacol 2004;67:1139\u201351.", "ArticleIdList": ["15006550"]}, {"Citation": "Luqmani Y. Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract 2005;14(Suppl 1):35\u201348.", "ArticleIdList": ["16103712"]}, {"Citation": "Nahta R, Yuan LX, Du Y, Esteva FJ.. Lapatinib induces apoptosis in trastuzumab-resistant breast cancer cells: effects on insulin-like growth factor I signaling. Mol Cancer Ther 2007;6:667\u201374.", "ArticleIdList": ["17308062"]}, {"Citation": "Ling YH, Lin R, Perez-Soler R.. Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK. Mol Pharmacol 2008;74:793\u2013806.", "ArticleIdList": ["18524889"]}, {"Citation": "Chao T-T, Wang C-Y, Chen Y-L, et al. . Afatinib induces apoptosis in NSCLC without EGFR mutation through Elk-1-mediated suppression of CIP2A. Oncotarget 2015;6:2164\u201379.", "ArticleIdList": ["PMC4385843", "25537503"]}, {"Citation": "Zhao Z-Q, Yu Z-Y, Li J, Ouyang X-N.. Gefitinib induces lung cancer cell autophagy and apoptosis via blockade of the PI3K/AKT/mTOR pathway. Oncol Lett 2016;12:63\u20138.", "ArticleIdList": ["PMC4906680", "27347100"]}, {"Citation": "George JA, Alshebli Z, Alneyadi A, et al. . Idelalisib induces apoptosis in the lymphoid tissues and impairs lung function in mice. J Chemother 2020;32:88\u201397.", "ArticleIdList": ["31884896"]}, {"Citation": "Ghorab MM, Alsaid MS, Soliman AM, Al-Mishari AA.. Benzo[g]quinazolin-based scaffold derivatives as dual EGFR/HER2 inhibitors. J Enzyme Inhib Med Chem 2018;33:67\u201373.", "ArticleIdList": ["PMC6010119", "29098904"]}, {"Citation": "Traxler P. Tyrosine kinases as targets in cancer therapy - successes and failures. Expert Opin Ther Targets 2003;7:215\u201334.", "ArticleIdList": ["12667099"]}, {"Citation": "Wakeling AE, Guy SP, Woodburn JR, et al. . ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Res 2002;62:5749\u201354.", "ArticleIdList": ["12384534"]}, {"Citation": "Gong HH, Addla D, Lv JS, Zhou CH.. Heterocyclic naphthalimides as new skeleton structure of compounds with increasingly expanding relational medicinal applications. Curr Top Med Chem 2016;16:3303\u201364.", "ArticleIdList": ["27150364"]}, {"Citation": "Kashyap M, Das D, Preet R, et al. . Scaffold hybridization in generation of indenoindolones as anticancer agents that induce apoptosis with cell cycle arrest at G2/M phase. Bioorg Med Chem Lett 2012;22:2474\u20139.", "ArticleIdList": ["22381050"]}, {"Citation": "Lubenets V, Lviv Polytechnic National University, Karpenko O, Ponomarenko M, Zahoriy G, Krychkovska A, Novikov V.. Development of new antimicrobial compositions of thiosulfonate structure. Chem Chem Technol 2013;7:119\u201324."}, {"Citation": "Lubenets V, Vasylyuk S, Monka N, et al. . Synthesis and antimicrobial properties of 4-acylaminobenzenethiosulfoacid S-esters. Saudi Pharm J 2017;25:266\u201374.", "ArticleIdList": ["PMC5355547", "28344478"]}, {"Citation": "Harmey JH, Bouchier\u2010Hayes D.. Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: Implications for anti-angiogenic therapy. Bioessays 2002;24:280\u20133.", "ArticleIdList": ["11891765"]}, {"Citation": "Gorski DH, Beckett MA, Jaskowiak NT, et al. . Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 1999;59:3374\u20138.", "ArticleIdList": ["10416597"]}, {"Citation": "Ghorab MM, El Ella DAA, Heiba HI, Soliman AM.. Synthesis of certain new thiazole derivatives bearing a sulfonamide moiety with expected anticancer and radiosensitizing activities. J Mater Sci 2011;3:31."}, {"Citation": "Mills CC, Kolb EA, Sampson VB.. Development of chemotherapy with cell-cycle inhibitors for adult and pediatric cancer therapy. Cancer Res 2018;78:320\u20135.", "ArticleIdList": ["PMC5771851", "29311160"]}, {"Citation": "Bai J, Li Y, Zhang G.. Cell cycle regulation and anticancer drug discovery. Cancer Biol Med 2017;14:348\u201362.", "ArticleIdList": ["PMC5785171", "29372101"]}, {"Citation": "Heishima K, Mori T, Sakai H, et al. . MicroRNA-214 promotes apoptosis in canine hemangiosarcoma by targeting the COP1-p53 axis. PLoS One 2015;10:e0137361.", "ArticleIdList": ["PMC4559432", "26335793"]}, {"Citation": "Hanahan D, Weinberg RA.. Hallmarks of cancer: the next generation. Cell 2011;144:646\u201374.", "ArticleIdList": ["21376230"]}, {"Citation": "Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 2005;5:876\u201385.", "ArticleIdList": ["16239906"]}, {"Citation": "Plesca D, Mazumder S, Almasan A.. DNA damage response and apoptosis. Methods Enzymol 2008;446:107\u201322.", "ArticleIdList": ["PMC2911482", "18603118"]}, {"Citation": "Kale J, Osterlund EJ, Andrews DW.. BCL-2 family proteins: changing partners in the dance towards death. Cell Death Differ 2018;25:65\u201380.", "ArticleIdList": ["PMC5729540", "29149100"]}, {"Citation": "Perlman H, Zhang X, Chen MW, et al. . An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis. Cell Death Differ 1999;6:48\u201354.", "ArticleIdList": ["10200547"]}, {"Citation": "Al-Shabib NA, Khan JM, Malik A, et al. . Molecular insight into binding behavior of polyphenol (rutin) with beta lactoglobulin: spectroscopic, molecular docking and MD simulation studies. J Mol Liquids 2018;269:511\u201320."}, {"Citation": "Campbell KJ, Tait SWG.. Targeting BCL-2 regulated apoptosis in cancer. Open Biol 2018;8:180002.", "ArticleIdList": ["PMC5990650", "29769323"]}, {"Citation": "Salam AAA, Nayek U, Sunil D.. Homology modeling and docking studies of Bcl-2 and Bcl-xL with small molecule inhibitors: identification and functional studies. Curr Top Med Chem 2018;18:2633\u201363.", "ArticleIdList": ["30659540"]}, {"Citation": "Alqahtani AS, Nasr FA, Noman OM, et al. . Cytotoxic evaluation and anti-angiogenic effects of two furano-sesquiterpenoids from Commiphora myrrh resin. Molecules 2020;25:1318.", "ArticleIdList": ["PMC7144466", "32183153"]}, {"Citation": "Porter J, Payne A, de Candole B, et al. . Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors. Bioorg Med Chem Lett 2009;19:230\u20133.", "ArticleIdList": ["19027294"]}, {"Citation": "Rehman MT, Shamsi H, Khan AU.. Insight into the binding mechanism of imipenem to human serum albumin by spectroscopic and computational approaches. Mol Pharm 2014;11:1785\u201397.", "ArticleIdList": ["24745377"]}, {"Citation": "Rabbani N, Tabrez S, Islam BU, et al. . Characterization of colchicine binding with normal and glycated albumin: In vitro and molecular docking analysis. J Biomol Struct Dyn 2018;36:3453\u201362.", "ArticleIdList": ["28990867"]}, {"Citation": "Rehman MT, Ahmed S, Khan AU.. Interaction of meropenem with 'N' and 'B' isoforms of human serum albumin: a spectroscopic and molecular docking study. J Biomol Struct Dyn 2016;34:1849\u201364.", "ArticleIdList": ["26372227"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "13", "Hour": "11", "Minute": "26"}, {"Year": "2021", "Month": "12", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "11"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34894963", "PMC8667930", "10.1080/14756366.2021.1983807"]}}], "PubmedBookArticle": []}